Showing results (101-110 of 362) with videos related to
Sort By:
Pageof 37
Cancer Treatment Reviews|September 1, 1983
Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapyM E Scheulen, K Bremer, N Niederle, et al.Anti-Cancer Drugs|June 1, 1996
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell linesD Strumberg, A Harstrick, K Doll, et al.Cancer Research|March 1, 1987
Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycinA A Miller, C G SchmidtBritish Journal of Cancer|September 1, 1982
Effects of cisplatin on different haemopoietic progenitor cells in miceM R Nowrousian, C G SchmidtInvestigational New Drugs|January 1, 1984
Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in miceM R Nowrousian, C G SchmidtArzneimittel-Forschung|January 1, 1982
[Comparison of the sensitivity of various mouse hematopoietic stem cells to cis-diamminodichloroplatinum (II)]M R Nowrousian, C G SchmidtCancer Chemotherapy and Pharmacology|January 1, 1982
Haematopoietic late effects of prolonged bleomycin treatment in miceM R Nowrousian, C G SchmidtJournal of Cancer Research and Clinical Oncology|April 27, 2000
Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell linesM M Heim, W Eberhardt, S Seeber, et al.Cancer Genetics and Cytogenetics|March 1, 1995
Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formationG Prescher, N Bornfeld, W Friedrichs, et al.International Journal of Oncology|April 17, 2002
A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)S Kasimir-Bauer, C Oberhoff, A E Schindler, et al.Pageof 37